May 18, 2006

Bayer bond issues successfully placed

Leverkusen, May 18, 2006 - Bayer today successfully placed three bond issues
totaling approximately EUR 3 billion. The proceeds will be used to replace a portion
of the bridging facility provided by Citigroup and Credit Suisse to partially refinance
the planned acquisition of Schering.

A three-year floating-rate Eurobond in the amount of EUR 1.6 billion will bear
interest at 22.5 basis points over Euribor. The seven-year fixed-rate Eurobond with a
volume of EUR 1.0 billion carries a 4.5 % coupon and is priced at 55 basis points
(0.55%) over swaps. The 12-year fixed-rate sterling bond in the amount of GBP 250
million carries a 5.625 percent coupon and a spread of 106 basis points (1.06 %) over
sterling benchmark.

Since the issues met with great interest on the capital market, the transactions were
completed on schedule. At the end of March the company already placed a
subordinated mandatory convertible bond with a volume of EUR 2.3 billion including
greenshoe, and successfully closed the syndication of a EUR 7 billion loan on May 11.

Forward-looking statements<br/>
This announcement contains forward-looking statements based on current assumptions and forecasts made by
Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to
material differences between the actual future results, financial situation, development or performance of the
company and the estimates given here. These factors include those we discussed in our annual and interim
reports to the Frankfurt Stock Exchange and in our reports filed with the SEC (including Form 20-F). The
company does not assume any liability whatsoever to update these forward-looking statements or to conform
them to future events or developments.

This announcement is for general information only and does not form part of any offer to sell, or the solicitation
of any offer to buy, securities. The distribution of this announcement and the offer and sale of the securities
described in this announcement in certain jurisdictions may be restricted by law. Any persons reading this
announcement should inform themselves of and observe any such restrictions. This announcement may not be
taken, distributed or transmitted, directly or indirectly, in any form in or into Italy, the United States, Canada or
Japan. This announcement is not an offer of securities for sale in the United States. The offer and sale of the
securities referred to in this announcement has not been, nor will it be, registered under the United States
Securities Act of 1933 and the securities referred to in this announcement may not be offered or sold in the
United States absent such registration or an applicable exemption from registration. There will be no public offer
of these securities in the United States.

This communication is directed only at persons who (i) are outside Italy, the United Kingdom, the United States,
Canada or Japan or (ii) have professional experience in matters relating to investments or (iii) are persons falling
within Article 49 (2)(a) to (d) ("high net worth companies, unincorporated associations etc") of The Financial
Services and Markets Act 2000 (Financial Promotion) Order 2001 (all such persons together being referred to as
"relevant persons"). This communication must not be acted on or relied on by persons who are not relevant
persons. Any investment or investment activity to which this communication relates is available only to relevant
persons and will be engaged in only with relevant persons.

This announcement is not an offer of securities for sale in Germany and is not a listing prospectus according to
the German Securities Prospectus Act (Wertpapierprospektgesetz) as amended, the Commission Regulation
(EC) No 809/2004 of 29 April 2004 as amended, or any other laws applicable in Germany governing the issue,
offering and sale of securities. Any investment decisions or advices for investment decisions should only be
made or given based on a prospectus which also includes a section on risk factors.



Current Event

November 3, 2020

Q3 2020 Quarterly Statement